WOODLEA HOUSE SURGERY — All Prescriptions & Medications — Page 7
Practice Code: J81633 | BOURNEMOUTH, BH8 9NX
Showing results 301-350 of 539
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Canagliflozin | 42 | 1,576 | £2.0K | -70.7% ▼ |
| Hydrocortisone | 42 | 6,396 | £1.4K | -50.3% ▼ |
| Fesoterodine fumarate | 42 | 1,708 | £144 | +6.5% ▲ |
| Anastrozole | 42 | 1,316 | £50 | -53.9% ▼ |
| Permethrin | 42 | 3,000 | £897 | +11.5% ▲ |
| 42 | 602 | £710 | +29.8% ▲ | |
| Telmisartan | 41 | 1,652 | £398 | -29.3% ▼ |
| Guanfacine | 41 | 1,372 | £3.0K | +59.6% ▲ |
| Insulin Lispro | 41 | 327 | £2.0K | -46.4% ▼ |
| Specialist food replacer rolls/baguettes (0913271) | 41 | 42.0K | £585 | +69.8% ▲ |
| Acetazolamide | 41 | 3,892 | £148 | +89.2% ▲ |
| 41 | 4,836 | £278 | -40.1% ▼ | |
| 41 | 2,190 | £1.9K | +1.1% vs avg | |
| Benzoyl peroxide and clindamycin phosphate | 40 | 1,620 | £701 | -40.3% ▼ |
| Dexamethasone | 39 | 1,359 | £134 | +25.1% ▲ |
| Adapalene and benzoyl peroxide | 39 | 1,800 | £782 | -27.0% ▼ |
| 39 | 424 | £3.3K | +84.5% ▲ | |
| Hydrocortisone | 38 | 958 | £221 | -50.0% ▼ |
| Dosulepin hydrochloride | 38 | 1,400 | £273 | -32.9% ▼ |
| Rivastigmine | 38 | 1,130 | £1.8K | -44.8% ▼ |
| Alprostadil | 38 | 130 | £1.6K | +122.2% ▲ |
| Celecoxib | 38 | 2,670 | £174 | -42.5% ▼ |
| 38 | 120 | £29 | +6.6% ▲ | |
| 38 | 315 | £663 | +160.2% ▲ | |
| Valsartan | 37 | 1,736 | £400 | -37.2% ▼ |
| Water for injection | 37 | 420 | £123 | +9.4% ▲ |
| Terbutaline sulphate | 36 | 41 | £324 | -33.6% ▼ |
| Dexamethasone | 36 | 215 | £69 | -39.7% ▼ |
| Fluorouracil (Sunscreen) | 36 | 1,410 | £1.1K | -1.2% vs avg |
| 36 | 254 | £242 | +9.7% ▲ | |
| Rizatriptan | 35 | 312 | £1.1K | -41.1% ▼ |
| Zonisamide | 35 | 3,976 | £2.8K | -19.8% ▼ |
| 35 | 5,050 | £9.1K | -28.2% ▼ | |
| Buprenorphine | 34 | 140 | £853 | -90.7% ▼ |
| Powder extensively hydrolysed formula (0913101) | 34 | 79.2K | £2.2K | -52.8% ▼ |
| 34 | 6,290 | £191 | -60.1% ▼ | |
| Ferrous gluconate | 33 | 1,910 | £52 | -31.0% ▼ |
| Other individually formulated bought in preparations | 33 | 390 | £102 | +1.0% vs avg |
| 33 | 1,132 | £1.7K | +29.9% ▲ | |
| 33 | 33 | £77 | +1.8% vs avg | |
| Risedronate sodium | 32 | 148 | £40 | -73.6% ▼ |
| Mefenamic acid | 32 | 1,232 | £222 | -29.2% ▼ |
| Clindamycin phosphate | 32 | 1,410 | £264 | +94.5% ▲ |
| Ketoconazole | 32 | 990 | £133 | +221.7% ▲ |
| Midazolam hydrochloride | 32 | 270 | £148 | -21.8% ▼ |
| 32 | 5,835 | £60 | +27.2% ▲ | |
| 32 | 1,000 | £2.6K | +71.4% ▲ | |
| Sotalol hydrochloride | 31 | 1,792 | £77 | -55.9% ▼ |
| Umeclidinium bromide | 31 | 31 | £810 | -49.7% ▼ |
| Cyclizine lactate | 31 | 324 | £289 | +106.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.